推薦產(chǎn)品
3-(4-chlorophenyl)-4-phenyl-4,5-dihydro-1H-pyrazole 2-(chloromethyl)-3-methylpyridinehydrochloride 1-(2-bromo-4-methylphenyl)ethanone 3-chloroisoquinoline-4-carbonitrile 5,8-dichloropyrido[3,2-d]pyridazine 2-bromomalononitrile 2-(4-(bromomethyl)phenyl)benzo[d]thiazole 1-(bromomethyl)-3-methoxy-2-nitrobenzene 6-bromo-1H-[1,2,3]triazolo[4,5-b]pyridine 4-iodo-2-((trimethylsilyloxy)methyl)thiazole 6-iodoimidazo[1,2-a]pyridine-3-carbonitrile 2-(4-chlorophenyl)-2-morpholinoacetonitrile 4-chloro-7H-pyrrolo[2,3-d]pyrimidine 4-chloroisothiazole 5-bromo-6-chloro-1H-indole 7-chloro-3H-imidazo[4,5-b]pyridine ethyl3-(4-formylphenyl)propanoate 2,3-dibromobenzaldehyde 1-(5H-chromeno[2,3-b]pyridin-7-yl)ethanone 5H-chromeno[2,3-b]pyridin-5-one 3-chloroisoquinoline-4-carbaldehyde (E)-2-(3-oxoprop-1-enyl)benzaldehyde methyl4-formyl-3-nitrobenzoate 5,6-dimethoxy-2,2-dimethyl-2,3-dihydro-1H-inden-1-one 1-methylbicyclo[4.1.0]heptan-3-one 3-nitro-4-(trifluoromethoxy)benzaldehyde 2-hydroxyquinoline-6-carbaldehyde 2-nitro-3-(trifluoromethyl)benzaldehyde 1-(2-fluoro-4-methoxyphenyl)propan-2-one tert-butyl3-fluoro-4-oxopiperidine-1-carboxylate tert-butyl3-oxopropylcarbamate 2,2-dimethylcyclohexanone 9H-carbazole-3-carbaldehyde N,N-dimethyl-2-oxoacetamide 2-methylpent-4-yn-2-ol 3-tert-butyl-4-hydroxybenzonitrile 4-bromo-2-tert-butylphenol 1,3-dibutoxypropan-2-ol methyl4-hydroxyquinoline-6-carboxylate methyl3-cyano-4-hydroxybenzoate 4-chloro-6-methoxyquinolin-7-ol 3,4-dihydro-2H-benzo[b][1,4]oxazin-7-ol 2-(2-aminothiazol-5-yl)ethanolhydrochloride (R)-ethyl2-chloropropanoate (S)-4-amino-5-(4,4-dimethylcyclohexylamino)-5-oxopentanoicacid (1s,4s)-4-hydroxycyclohexanecarboxylicacid (S)-2-(tetrahydrofuran-3-yloxy)aceticacid (1S,4R)-1-methyl-4-(prop-1-en-2-yl)cyclohex-2-enol (R)-4-(hydroxymethyl)oxazolidin-2-one (S)-4-(hydroxymethyl)oxazolidin-2-one 化工資訊 日前，內(nèi)蒙古騰龍生物精細(xì)化工有限公司位于內(nèi)蒙古烏達(dá)工業(yè)園區(qū)內(nèi)的二期新建3萬噸草甘膦系列項目正在進(jìn)行設(shè)備調(diào)試。該項目總投資4.6億元，新建3萬噸草甘膦、環(huán)保水處理工程及配套建設(shè)車間，三氯化磷車間，甲醇回收、三乙胺回收、氯甲烷回收裝置，蒸汽、冷凍、循環(huán)水、空壓站、配電站等公用工程。項目將使公司現(xiàn)有生產(chǎn)產(chǎn)能達(dá)到草甘膦5萬噸/年，銷售收入達(dá)15億元。
據(jù)了解，2013年9月，內(nèi)蒙古騰龍在充分調(diào)研國內(nèi)外草甘膦市場的基礎(chǔ)上，抓住西部大開發(fā)的歷史機遇，計劃對生產(chǎn)布局進(jìn)行適時調(diào)整，在多次考察烏海市烏達(dá)經(jīng)濟(jì)開發(fā)區(qū)的投資環(huán)境后，提出在烏達(dá)經(jīng)濟(jì)開發(fā)區(qū)分兩期實施草甘膦項目。項目主要采用甘氨酸、亞磷酸二甲酯工藝，以甘氨酸為起始原料，與多聚甲醛、亞磷酸二甲酯經(jīng)加成、縮合、水解而得草甘膦。一期工程草甘膦、氯乙酸、二甲酯和配套公用工程車間等已建成投產(chǎn)。
內(nèi)蒙古騰龍生物精細(xì)化工有限公司創(chuàng)建于2010年，是由湖北宜化集團(tuán)與江蘇騰龍集團(tuán)合作在內(nèi)蒙古烏海市烏達(dá)經(jīng)濟(jì)開發(fā)區(qū)投資新組建的化工企業(yè)，項目總投資10億元，主要從事精細(xì)生物化工、農(nóng)藥中間體、醫(yī)藥中間體、生物化學(xué)農(nóng)藥生產(chǎn)。
